Fiche publication
Date publication
février 2026
Journal
JMIR cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr LAMBERT Aurélien
,
Dr FAIVRE Jean-Christophe
Tous les auteurs :
Claessens A, Simon A, Manchart A, Desmonts L, Leguay C, Faivre JC, Cambier S, Salleron J, Lambert A
Lien Pubmed
Résumé
Screening for clinical trials is challenging for clinicians due to its time-consuming and repetitive nature. The rise of artificial intelligence (AI) offers an opportunity to improve screening productivity and reproducibility. Pancreatic cancer is characterized by increasing incidence, poor survival outcomes, and an urgent need for improved management strategies.
Mots clés
AI, artificial intelligence, clinical trials as topic, pancreatic neoplasms, pilot project, reproducibility of results
Référence
JMIR Cancer. 2026 02 23;12:e80268
